Zealand Pharma A/S (LON:0NZU)
London · Delayed Price · Currency is GBP · Price in DKK 510.02
+47.95 (10.38%)
At close: Oct 31, 2025
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 4.24 billion as of November 3, 2025. Its market cap has decreased by -31.96% in one year.
Market Cap
4.24B
Enterprise Value
2.34B
Revenue
1.05B
Ranking
n/a
PE Ratio
5.53
Stock Price
510.02
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 159.84M to 4.24B, an increase of 2,555.49%. That is a compound annual growth rate of 24.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 4.24B | -24.50% |
| Dec 30, 2024 | 5.62B | 121.65% |
| Dec 29, 2023 | 2.54B | 105.19% |
| Dec 30, 2022 | 1.24B | 74.70% |
| Dec 30, 2021 | 707.55M | -33.54% |
| Dec 30, 2020 | 1.06B | 9.92% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| HSBC Holdings | 182.60B |
| Shell | 164.70B |
| Unilever | 114.25B |
| Rolls-Royce Holdings | 98.20B |
| Rio Tinto Group | 93.32B |
| British American Tobacco p.l.c. | 84.99B |
| GSK plc | 71.57B |